ストックスクリーナーアプリを入手
9.81
1.31%
-0.13
アフターアワーズ：
9.82
0.010
+0.10%
前日終値:
$9.94
開ける：
$9.9
24時間の取引高:
2.62M
Relative Volume:
0.47
時価総額：
$2.55B
収益：
$6.29B
当期純損益:
$750.00M
株価収益率:
3.4063
EPS:
2.88
ネットキャッシュフロー:
$586.00M
1週間 パフォーマンス:
+0.93%
1か月 パフォーマンス:
-2.29%
6か月 パフォーマンス:
-37.95%
1年 パフォーマンス:
-53.94%
1日の値動き範囲:
$9.765
$10.01
1週間の範囲:
$9.71
$10.27
52週間の値動き範囲:
$8.01
$23.10
Organon Co Stock (OGN) Company Profile
OGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
9.81 | 2.53B | 6.29B | 750.00M | 586.00M | 2.88 |
|
LLY
Lilly Eli Co
|
799.34 | 693.83B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
156.82 | 373.59B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
191.52 | 331.43B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
121.04 | 241.20B | 53.22B | 12.86B | 14.85B | 6.39 |
|
NVO
Novo Nordisk Adr
|
68.94 | 308.01B | 43.59B | 15.04B | 10.74B | 3.3766 |
Organon Co Stock (OGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-09-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-11-03 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-21 | 開始されました | Barclays | Overweight |
| 2023-03-16 | 開始されました | Raymond James | Outperform |
| 2022-10-14 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 開始されました | Piper Sandler | Neutral |
| 2021-09-01 | 開始されました | BofA Securities | Buy |
| 2021-07-22 | 開始されました | Citigroup | Buy |
| 2021-06-15 | 開始されました | JP Morgan | Neutral |
| 2021-06-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Organon Co (OGN) 最新ニュース
Organon & Co. Investors: Please contact the Portnoy Law - GlobeNewswire
Organon & Co. (OGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming DeadlinesOGN - FinancialContent
ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT Bernstein - GlobeNewswire
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm - WV News
Organon & Co. (NYSE:OGN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Teacher Retirement System of Texas Decreases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World
Organon & Co. (OGN) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 22, 2025 - Stockhouse
OGN IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action – OGN - TradingView
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Organon & Co. (OGN) Investors of July 22, 2025 Deadline - Stockhouse
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Organon, UroGen and Fortrea and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
OGN FRAUD ALERT: Organon & Co. 27% Stock Drop Triggers - GlobeNewswire
Organon & Co. Sued for Securities Law Violations – - GlobeNewswire
Organon & Co.'s VTAMA Cream: A Breakthrough in Atopic Dermatitis and a Growth Catalyst for OGN - AInvest
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Act Now or Risk Losses: Organon Investors Face Critical July 22 Deadline in Securities Fraud Lawsuit - AInvest
Deadline Alert: Organon & Co. (OGN) Investors Who Lost - GlobeNewswire
Organon & Co. (OGN) Announces American Academy of Dermatology’s Strong Recommendation for VTAMA Cream - Insider Monkey
Organon & Co. Securities Fraud Class Action Lawsuit - GlobeNewswire
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Yahoo
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Organon & Co.OGN - GlobeNewswire
Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance
Organon & Co. Sued for Securities Law ViolationsContact - GlobeNewswire
OGN Shareholders Have the Right to Lead the Organon & Co. Securities LawsuitContact the DJS Law Group to Discuss Your RightsOGN - Morningstar
With 79% ownership of the shares, Organon & Co. (NYSE:OGN) is heavily dominated by institutional owners - Yahoo Finance
OGN Stock News: Robbins LLP Reminds Organon & Co. Investors - GlobeNewswire
INVESTOR DEADLINE: Robbins Geller Announces that Organon & - GlobeNewswire
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
ORGANON & CO. (NYSE: OGN) INVESTOR ALERT: Investors With - GlobeNewswire
ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.OGN - TradingView
ROSEN, A RANKED AND LEADING FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming DeadlinesOGN - TradingView
July 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against OGN - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - GlobeNewswire
Yousif Capital Management LLC Cuts Position in Organon & Co. (NYSE:OGN) - Defense World
Organon: A Look Beyond The Dividend Cut (NYSE:OGN) - Seeking Alpha
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY - GlobeNewswire
Investors who lost money on Organon & Co.(OGN) should contact Levi & Korsinsky about pending Class ActionOGN - PR Newswire
Organon: Persistent Headwinds Make This A Hold - Seeking Alpha
Investor Alert: Deadline Approaching to Join Organon & Co. (OGN) Class ActionContact Levi & Korsinsky - ACCESS Newswire
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit - PR Newswire
Organon (OGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Class Action Filed Against Organon & Co. (OGN)July 22, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
OGN SHAREHOLDER REPORT: Organon & Co. was Sued for Fraud – - GlobeNewswire
Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - PR Newswire
Class Action Lawsuit Filed Against Organon & Co. (OGN)Recover LossesContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
Investors in Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to Discuss Your RightsOGN - WV News
Securities Class Action Lawsuit Filed Against Organon & Co. (OGN)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Organon Co (OGN) 財務データ
収益
当期純利益
現金流量
EPS
Organon Co (OGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Falcione Aaron | Chief Human Resources Officer |
May 07 '25 |
Buy |
8.77 |
5,500 |
48,235 |
62,974 |
| Weaver Kirke | Gen. Counsel & Corp. Secy. |
May 06 '25 |
Buy |
9.21 |
8,045 |
74,054 |
52,489 |
| Karp Daniel | Executive VP, Corp. Dev. |
May 06 '25 |
Buy |
8.24 |
3,500 |
28,828 |
46,669 |
| WALSH MATTHEW M | Chief Financial Officer |
May 05 '25 |
Buy |
8.82 |
11,400 |
100,548 |
144,484 |
| Ali Kevin | Chief Executive Officer |
May 05 '25 |
Buy |
8.80 |
34,000 |
299,370 |
282,731 |
| Falcione Aaron | Chief Human Resources Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
18,732 |
0 |
59,237 |
| Karp Daniel | Executive VP, Corp. Dev. |
Mar 31 '25 |
Option Exercise |
0.00 |
34,677 |
0 |
44,515 |
| Stahler Rachel A | Chief Information Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
18,334 |
0 |
78,994 |
| WALSH MATTHEW M | Chief Financial Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
34,870 |
0 |
136,903 |
| Arjona Ferreira Juan Camilo | Head of R&D & CMO |
Mar 31 '25 |
Option Exercise |
0.00 |
8,865 |
0 |
20,552 |
0.12%
2.23%
大文字化:
|
ボリューム (24 時間):